Er Acarix på vej ind på markedet? Det har været en lang ørkenvandring med talrige emissioner, men kan de knække koden, og få fat i USA, så kunne den MÅSKE blive interessant....En STOR lodseddel :). Acarix secures a multi-unit order from major cardiology practice with several offices in Florida
I dag kl. 09:45 ∙ MFN
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multiple clinics within Miami's Amavita Heart and Vascular Health™, a leading cardiovascular practice.
"We take pride in our ability to offer state-of-the-art testing and diagnostics while providing value-based quality care to our patients," stated Dr. Pedro Martinez-Clark, MD, FACC, founder and interventional cardiologist. "Incorporating the CADScor System into the diagnostic toolbox allows us to provide patients with suspected coronary artery disease a fast and easy test with results at the point of care. We acknowledge that waiting for results can be an anxiety-inducing experience for patients, so we have minimized the wait time by including the CADScor System in our diagnostic workflow. Instead of our patients waiting to receive results, they can immediately start working with our team to focus on the next steps to address their needs."
Amavita Heart and Vascular Health™ operates several locations throughout Miami-Dade County, enabling the practice to serve patients across South Florida. Their main objective is to enhance cardiovascular outcomes using advanced technology and interventions while providing empathetic care to all patients.
"We are pleased to announce the incorporation of the CADScor System within an advanced facility like Amavita Heart and Vascular Health™," commented Acarix President & CEO Aamir Mahmood. "The CADScor System represents a pivotal step towards value-based care in cardiology. Providing an accurate and non-invasive tool for risk stratification of coronary artery disease at the point of care empowers clinicians to tailor decisions more precisely, leading to better outcomes and cost-effective care. This technology enhances the patient experience by minimizing unnecessary procedures and aligns with the healthcare industry's shift towards value-driven practices, where quality and efficiency are paramount."
I dag kl. 09:45 ∙ MFN
Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, has announced that the CADScor System is now available at multiple clinics within Miami's Amavita Heart and Vascular Health™, a leading cardiovascular practice.
"We take pride in our ability to offer state-of-the-art testing and diagnostics while providing value-based quality care to our patients," stated Dr. Pedro Martinez-Clark, MD, FACC, founder and interventional cardiologist. "Incorporating the CADScor System into the diagnostic toolbox allows us to provide patients with suspected coronary artery disease a fast and easy test with results at the point of care. We acknowledge that waiting for results can be an anxiety-inducing experience for patients, so we have minimized the wait time by including the CADScor System in our diagnostic workflow. Instead of our patients waiting to receive results, they can immediately start working with our team to focus on the next steps to address their needs."
Amavita Heart and Vascular Health™ operates several locations throughout Miami-Dade County, enabling the practice to serve patients across South Florida. Their main objective is to enhance cardiovascular outcomes using advanced technology and interventions while providing empathetic care to all patients.
"We are pleased to announce the incorporation of the CADScor System within an advanced facility like Amavita Heart and Vascular Health™," commented Acarix President & CEO Aamir Mahmood. "The CADScor System represents a pivotal step towards value-based care in cardiology. Providing an accurate and non-invasive tool for risk stratification of coronary artery disease at the point of care empowers clinicians to tailor decisions more precisely, leading to better outcomes and cost-effective care. This technology enhances the patient experience by minimizing unnecessary procedures and aligns with the healthcare industry's shift towards value-driven practices, where quality and efficiency are paramount."
13/5 2024 11:57 Plada 0
120381 Nu er ca. 20% af aktier på amerikanske hænder, og det er her markedet er størst. Acarix er lige begyndt, og jeg tror EPS er tæt / eller over 0,0 Sek.
14/5 2024 16:06 Plada 0120421 CEO, Aamir anser 200.000 patches for muligt inden for overskuelig tid. VA & IDN budgetterne er ikke forhandlet i hus endnu. -Ser jeg frem til.
